Life Science Legal Strategy Summit relocates to Frankfurt with IPKat discount on Early Bird rate

Kat-approved networking

The Katfriends at Kisaco Research wish to inform IPKat readers that the Life Science Legal Strategy Summit is relocating to Frankfurt for 2026, taking place at the Frankfurt Marriott Hotel on 13-14 October. The agenda is available here.

Now in its 5th edition, the Life Science Legal Strategy Summit unites together in-house counsel with law firms, regulators, judges and more for two days of in-depth discussion across IP, regulatory, competition and corporate law.

450+ attendees and 60+ speakers are expected, with a 50% in-house audience. 225+ in-house counsel are confirmed, with companies including AbbVie, Bayer, Eli Lilly, Johnson & Johnson, MSD, Novartis, Novo Nordisk, Pfizer, Roche, Sandoz, and Sanofi.

For 2026, the summit offers two dedicated tracks – IP & Regulatory Exclusivities and Market Access, Deals & Competition – reflecting the full breadth of challenges shaping the life science sector today.

Programme highlights include:

• Keynote sessions on the EU Pharma Package & Biotech Act, geopolitics and competition law
• Panel sessions on topics ranging from antibody patenting and SPC strategy to AI-assisted inventions, clinical trials and second medical use
• An exclusive interview with the European Commission (DG COMP)
• Interactive roundtable sessions covering doctrine of equivalents, IP & trade secrets, SME transactions strategy, the SPC manufacturing waiver and more
• 10+ hours of dedicated networking, including a Networking Drinks Reception

Speakers include:

• Alex Ott – Sandoz
• Charlie Lou – Takeda
• Karen Guo – Novo Nordisk
• Markus Gruber – Novartis
• Rainer Friedrich – UPC & Boehringer Ingelheim
• Stefanie Kies – Polpharma Biologics

According to the organizers, participation in the Summit will allow to:

• Access practical insights delegates can apply to their work
• Address key concerns around patentability and BoA decisions to take directly to client work
• Connect with a 50% senior in-house counsel audience, actively seeking external counsel
• Meet patent disputes teams to gain technical expert referral work.

As Early Bird pricing is running this week only, IPKat readers are entitled to a 10% discount on top of the current Early Bird rate, using code IPKAT at checkout. To register, click here.